Vimarsana
Biggest News Aggregation in the World

Page 8 - Pharma Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Group Today - Breaking & Trending Today

LSL Pharma Group Announces Closing of Second Tranche of Convertible Debentures Offering - Vimarsana News

LSL Pharma Group Announces Closing of Second Tranche of Convertible Debentures Offering

LSL Pharma Group Inc. ? (the "Company" or "LSL Pharma Group"), a Canadian integrated pharmaceutical company, is pleased to announce that the Company has closed the second tranche of its brokered private placement (the "Offering") through the...

LSL Pharma Group Announces its Results for the Third Quarter of Fiscal 2023 - Vimarsana News

LSL Pharma Group Announces its Results for the Third Quarter of Fiscal 2023

LSL Pharma Group Inc. (the Company or ...

Outstanding 12-month first-in-human data from Xeltis' aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023 - Vimarsana News

Outstanding 12-month first-in-human data from Xeltis' aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023

Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023 aXess demonstrated exceptional patency rates and no infections to date EINDHOVEN, The Netherlands – 17 November 2023, Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, announces outstanding 12-month data from its first-in-human (FIH) aXess vascular conduit trial (NCT04898153). The data was presen

Source: yahoo.com
Rx Rundown: Legend Biotech, CureVac, Roivant Sciences and more - Vimarsana News

Rx Rundown: Legend Biotech, CureVac, Roivant Sciences and more

Check out this week’s medical marketing news, people on the move and industry chatter.

Syringes Market Size is Anticipated to Acquire USD 6.9 billion by 2031 | TMR (Analysis, Growth, Demand, Share, Outlook) - Vimarsana News

Syringes Market Size is Anticipated to Acquire USD 6.9 billion by 2031 | TMR (Analysis, Growth, Demand, Share, Outlook)

As the aging population and number of diseases increase, the demand for syringes in Europe is expected to increase.Wilmington, Delaware, United States, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The syringes market was worth US$ 4 billion in Europe in 2021. From 2022 to 2031, it is projected to grow at a CAGR of 5.6%. The market for syringes in Europe is estimated to reach US$ 6.9 billion by 2031. COVID-19 has increased global pandemic preparedness. A rapid and effecti

Source: yahoo.com